Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Capital Expenditures (2022 - 2026)

HeartSciences filings provide 4 years of Capital Expenditures readings, the most recent being -$9476.0 for Q1 2026.

  • On a quarterly basis, Capital Expenditures changed N/A to -$9476.0 in Q1 2026 year-over-year; TTM through Jan 2026 was $39323.0, a 33.96% decrease, with the full-year FY2025 number at $3157.0, down 95.1% from a year prior.
  • Capital Expenditures hit -$9476.0 in Q1 2026 for HeartSciences, down from $48799.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $48799.0 in Q2 2024 to a low of -$9476.0 in Q1 2026.
  • Median Capital Expenditures over the past 4 years was $6078.5 (2022), compared with a mean of $9160.9.
  • Biggest five-year swings in Capital Expenditures: tumbled 32.25% in 2023 and later surged 542.77% in 2024.
  • HeartSciences' Capital Expenditures stood at $7247.0 in 2022, then tumbled by 73.06% to $1952.0 in 2023, then soared by 2399.95% to $48799.0 in 2024, then tumbled by 119.42% to -$9476.0 in 2026.
  • The last three reported values for Capital Expenditures were -$9476.0 (Q1 2026), $48799.0 (Q2 2024), and $8794.0 (Q1 2024) per Business Quant data.